Topiramate
Product Images NDC 53217-315

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 53217-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi (Topiramate 50mg Tab For Cipla 1)

Chemical structure of the active ingredient Topiramate, showing its molecular configuration with labeled atoms and bonds depicted in a two-dimensional format.*

FDA Label Image

Topi (Topiramate 50mg Tab For Cipla 2)

A Kaplan-Meier curve chart showing cumulative rates over time in days, with two survival curves compared. The vertical axis is labeled 'Cumulative Rates for Time to Event' and the horizontal axis shows time in days from 0 to approximately 450. A p-value of 0.0002 is indicated on the right side.*

FDA Label Image

Topiramate 50mg Tab (Topiramate 50mg Tab For Cipla 3)

Topiramate USP 50 mg tablets packaging label by Aidarex Pharmaceuticals LLC. The label indicates a 30-count bottle of light orange round tablets, each containing 50 mg of Topiramate. The label also includes a lot number area, the manufacturer's name (Cipla Ltd., India), and NDC 53217-0315-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.